+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Veterinary Therapeutics Market - Global Forecast 2026-2032- Product Image
Veterinary Therapeutics Market - Global Forecast 2026-2032- Product Image
Sale

Veterinary Therapeutics Market - Global Forecast 2026-2032

  • Report

  • 194 Pages
  • August 2026
  • Region: Global
  • 360iResearch™
  • ID: 4989959
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Veterinary Therapeutics Market is projected to reach USD 55.36 Billion in 2026. It is expected to continue growing at a CAGR of 5.76%, reaching USD 78.29 Billion by 2032.

The veterinary therapeutics market is moving from reactive treatment toward prevention, precision care, and evidence-led disease management across companion animals, livestock, aquaculture, and equine health. Demand is supported by rising pet ownership, higher spending on animal wellness, intensifying livestock biosecurity requirements, and the One Health recognition that animal disease control directly affects human health, food security, and antimicrobial resistance.

Verified public-health agencies, including the World Health Organization, the Food and Agriculture Organization, and the World Organisation for Animal Health, consistently link animal health to zoonotic disease control, safe protein supply, and responsible antimicrobial use. This makes veterinary pharmaceuticals, vaccines, parasiticides, anti-infectives, pain management products, dermatology therapies, and biologics strategic assets for clinics, producers, distributors, and regulators.

Transformative Shifts in Veterinary Therapeutics

The landscape is being reshaped by three structural shifts: the humanization of pets, the professionalization of livestock health management, and the regulatory push for responsible antimicrobial use. Companion animal care is increasingly comparable to human healthcare, with stronger demand for chronic disease therapies, oncology, dermatology, pain control, ophthalmology, dental care, and specialty diagnostics.

In food-producing animals, preventive therapeutics, vaccination programs, herd health analytics, and biosecurity protocols are gaining priority as producers seek to reduce losses from infectious disease while meeting consumer, retailer, and regulator expectations for responsible antibiotic stewardship. Regulatory frameworks such as the U.S. Veterinary Feed Directive and the European Union’s veterinary medicinal product rules reinforce this transition by limiting routine antimicrobial use and strengthening oversight of veterinary prescriptions.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is becoming a practical accelerator for veterinary therapeutics rather than a distant concept. AI-enabled image interpretation, clinical decision support, digital pathology, wearable monitoring, and predictive herd analytics help veterinarians detect disease earlier, stratify risk, and choose therapies with better evidence. These tools can improve workflow efficiency in clinics and support proactive interventions in production systems.

AI is also influencing research and commercialization by improving target discovery, molecule screening, pharmacovigilance signal detection, adverse-event monitoring, and real-world evidence generation. Its impact depends on high-quality datasets, veterinary validation, cybersecurity, explainability, and regulatory alignment, especially when AI outputs influence diagnosis, prescribing, antimicrobial selection, or animal welfare decisions.

Key Regional Insights

Asia-Pacific is one of the most dynamic regions for veterinary therapeutics, supported by large livestock populations, expanding companion animal ownership, aquaculture intensity, and rising investment in local pharmaceutical manufacturing. China, India, Japan, South Korea, and Australia are central to demand across vaccines, parasiticides, anti-infectives, nutritional therapeutics, and specialty companion animal treatments, while regional authorities continue to strengthen disease surveillance, import controls, and antimicrobial stewardship.

North America remains highly developed due to advanced veterinary infrastructure, broad access to companion animal specialty care, established pet insurance adoption compared with many regions, mature distribution channels, and active oversight by the U.S. FDA Center for Veterinary Medicine, USDA, and Canadian regulators. Europe is shaped by stringent animal welfare standards, strong pharmacovigilance, and the European Union’s emphasis on reducing unnecessary antimicrobial use in food-producing animals. Latin America, led by Brazil and Mexico, benefits from large cattle, poultry, swine, and companion animal populations, creating sustained need for vaccines, parasiticides, reproductive health products, and herd disease management. The Middle East is expanding through premium pet care, equine medicine, falconry-related services, and food-security initiatives, while Africa presents long-term need for affordable vaccines, parasite control, cold-chain access, and livestock disease management aligned with transboundary disease prevention.

Key Group Insights

ASEAN markets are benefiting from rising protein consumption, commercial poultry and aquaculture growth, and a gradual shift from informal treatment to structured veterinary services. Demand is strongest where governments and producers prioritize disease surveillance, vaccination, farm productivity, and biosecurity programs addressing poultry, swine, aquaculture, and companion animal care.

The GCC is characterized by high-income companion animal care, equine health, falconry-related veterinary services, and strategic food-security programs that support demand for advanced diagnostics, vaccines, parasiticides, and specialty therapeutics. The European Union provides one of the world’s most regulated environments for veterinary medicines, with strict controls on antibiotics, pharmacovigilance, residue monitoring, and animal welfare. BRICS countries offer scale in livestock and companion animal demand, but vary widely in regulatory maturity, local manufacturing capacity, cold-chain performance, and distribution reliability. G7 markets lead in innovation, biologics, digital health, specialty care, and regulatory science, while NATO economies overlap with many advanced veterinary medicine markets that emphasize supply-chain resilience, biosecurity readiness, and secure access to essential veterinary medicines.

Key Country Insights

The United States leads in veterinary therapeutics innovation, companion animal specialty care, biologics, regulated animal drug approvals, and integrated clinical services supported by advanced diagnostics. Canada benefits from strong veterinary standards, livestock health programs, and antimicrobial stewardship initiatives, while Mexico combines companion animal growth with food-animal disease management needs across cattle, poultry, and swine systems. Brazil is a major demand center due to its global role in beef, poultry, and swine production, along with a large and growing companion animal base.

In Europe, the United Kingdom, Germany, France, Italy, and Spain support advanced companion animal care, high compliance expectations, and demand for therapies aligned with animal welfare and responsible prescribing, while Russia maintains demand across livestock and companion segments with distinct regulatory and supply-chain dynamics. China and India combine enormous animal populations with expanding domestic manufacturing, rising pet care demand, livestock vaccination needs, and increasing focus on food safety. Japan and South Korea emphasize premium companion animal care, senior pet health, high-quality regulation, and advanced clinical diagnostics, while Australia is shaped by livestock biosecurity, companion animal spending, equine health, and strict import controls that protect animal health status.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize differentiated portfolios that balance vaccines, parasiticides, chronic disease therapies, dermatology, pain management, and specialty companion animal products with responsible antimicrobial strategies. Organizations that invest in lifecycle management, palatable formulations, long-acting delivery, species-specific dosing, and robust clinical evidence can strengthen veterinarian adoption, producer confidence, and owner adherence.

Executives should also build regional regulatory capabilities, resilient supply chains, cold-chain reliability, and data partnerships with clinics, reference laboratories, universities, and livestock integrators. AI should be deployed where it improves clinical confidence, pharmacovigilance, customer support, field-force productivity, and herd-level decision-making, while maintaining transparent governance, data security, and veterinary oversight.

Research Methodology

This executive summary is based on secondary research from regulatory agencies, public-health organizations, veterinary associations, peer-reviewed literature, official trade and agriculture resources, and market intelligence frameworks. Key reference categories include FDA Center for Veterinary Medicine guidance, European veterinary medicine regulations, WOAH standards, FAO animal production resources, and WHO One Health and antimicrobial resistance materials.

The analysis triangulates qualitative indicators such as regulation, disease burden, antimicrobial stewardship policy, innovation activity, distribution maturity, animal ownership trends, livestock production systems, and veterinary service development. Insights are structured to support strategic planning, visibility, and executive decision-making without relying on unverified estimates, market sizing, market share, or unsupported forecasts.

Conclusion

Veterinary therapeutics is entering a period of disciplined advancement driven by prevention, precision medicine, stronger regulation, and the convergence of animal health with human health priorities. The most attractive opportunities are emerging where clinical evidence, digital enablement, responsible antimicrobial use, and practical field application meet clear unmet needs across companion animals, livestock, aquaculture, and equine care.

Organizations that align innovation with antimicrobial stewardship, regional disease realities, veterinarian workflows, producer requirements, and owner affordability will be best positioned to build durable advantage in the global veterinary therapeutics landscape.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Veterinary Therapeutics Market, by Product Type
7.1. Introduction
7.2. Biologics
7.2.1. Cell Therapies
7.2.2. Monoclonal Antibodies
7.2.3. Recombinant Proteins
7.3. Feed Additives
7.3.1. Enzymes
7.3.2. Prebiotics
7.3.3. Probiotics
7.4. Parasiticides
7.4.1. Ectoparasiticides
7.4.2. Endectocides
7.5. Pharmaceuticals
7.5.1. Anti-Inflammatories
7.5.2. Antibiotics
7.5.3. Hormones
7.6. Vaccines
7.6.1. Inactivated
7.6.2. Live Attenuated
7.6.3. Recombinant
8. Veterinary Therapeutics Market, by Animal Type
8.1. Introduction
8.2. Aquaculture
8.2.1. Crustaceans
8.2.2. Freshwater Fish
8.2.3. Marine Fish
8.3. Companion Animals
8.3.1. Avian
8.3.2. Canine
8.3.3. Feline
8.3.4. Rodents
8.4. Equine
8.4.1. Performance Horses
8.4.2. Racing Horses
8.4.3. Recreational Horses
8.5. Livestock
8.5.1. Cattle
8.5.2. Poultry
8.5.3. Sheep & Goats
8.5.4. Swine
9. Veterinary Therapeutics Market, by Route Of Administration
9.1. Introduction
9.2. Inhalation
9.3. Oral
9.4. Parenteral
9.4.1. Intradermal
9.4.2. Intramuscular
9.4.3. Intravenous
9.4.4. Subcutaneous
9.5. Topical
10. Veterinary Therapeutics Market, by Disease Type
10.1. Introduction
10.2. Behavioral Disorders
10.3. Infectious Diseases
10.4. Metabolic Disorders
10.5. Musculoskeletal Disorders
10.6. Parasitic Diseases
10.7. Reproductive Disorders
11. Veterinary Therapeutics Market, by End User
11.1. Introduction
11.2. Ambulatory Services
11.3. Online Channels
11.4. Retail Pharmacies
11.5. Veterinary Hospitals
12. Veterinary Therapeutics Market, by Distribution Channel
12.1. Introduction
12.2. Direct Sales
12.3. E-Commerce
12.4. Hospital Pharmacies
12.5. Retail Pharmacies
13. Veterinary Therapeutics Market, by Region
13.1. Asia-Pacific
13.2. North America
13.3. Latin America
13.4. Europe
13.5. Middle East
13.6. Africa
14. Veterinary Therapeutics Market, by Group
14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO
15. Veterinary Therapeutics Market, by Country
15.1. United States
15.2. Canada
15.3. Mexico
15.4. Brazil
15.5. United Kingdom
15.6. Germany
15.7. France
15.8. Russia
15.9. Italy
15.10. Spain
15.11. China
15.12. India
15.13. Japan
15.14. Australia
15.15. South Korea
16. Competitive Landscape
16.1. Market Share Analysis, 2025
16.2. FPNV Positioning Matrix, 2025
16.3. Market Concentration Analysis, 2025
16.3.1. Concentration Ratio (CR)
16.3.2. Herfindahl Hirschman Index (HHI)
16.4. Recent Developments & Impact Analysis, 2025
16.5. Product Portfolio Analysis, 2025
16.6. Benchmarking Analysis, 2025
17. Company Profiles
17.1. Ashish Life Science Private Limited
17.2. Biogenesis Bago S.A.
17.3. Boehringer Ingelheim International GmbH
17.4. Ceva Santé Animale
17.5. Dechra Pharmaceuticals PLC
17.6. Elanco Animal Health Incorporated
17.7. Hester Biosciences Limited
17.8. HIPRA, S.A.
17.9. Huvepharma EOOD
17.10. Indian Immunologicals Limited
17.11. Inovet Group
17.12. Intas Pharmaceuticals Limited
17.13. Kyoritsu Seiyaku Corporation
17.14. Merck & Co., Inc.
17.15. Neogen Corporation
17.16. Norbrook Laboratories Limited
17.17. Novartis AG
17.18. Ourofino Saúde Animal Participações S.A.
17.19. Phibro Animal Health Corporation
17.20. Sanofi S.A.
17.21. SeQuent Scientific Limited
17.22. Venkys (India) Limited
17.23. Vetoquinol S.A.
17.24. Virbac S.A.
17.25. Zoetis Inc.
17.26. Zydus Lifesciences Limited
List of Figures
FIGURE 1. GLOBAL VETERINARY THERAPEUTICS MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL VETERINARY THERAPEUTICS MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL VETERINARY THERAPEUTICS MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL VETERINARY THERAPEUTICS MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL VETERINARY THERAPEUTICS MARKET SIZE, 2024-2032 (USD MILLION)
FIGURE 6. GLOBAL VETERINARY THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
FIGURE 7. GLOBAL VETERINARY THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL VETERINARY THERAPEUTICS MARKET SIZE, BY ANIMAL TYPE, 2025 VS 2032 (%)
FIGURE 9. GLOBAL VETERINARY THERAPEUTICS MARKET SIZE, BY ANIMAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL VETERINARY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025 VS 2032 (%)
FIGURE 11. GLOBAL VETERINARY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL VETERINARY THERAPEUTICS MARKET SIZE, BY DISEASE TYPE, 2025 VS 2032 (%)
FIGURE 13. GLOBAL VETERINARY THERAPEUTICS MARKET SIZE, BY DISEASE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL VETERINARY THERAPEUTICS MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 15. GLOBAL VETERINARY THERAPEUTICS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL VETERINARY THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2032 (%)
FIGURE 17. GLOBAL VETERINARY THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL VETERINARY THERAPEUTICS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 19. GLOBAL VETERINARY THERAPEUTICS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL VETERINARY THERAPEUTICS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 21. GLOBAL VETERINARY THERAPEUTICS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL VETERINARY THERAPEUTICS MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 23. GLOBAL VETERINARY THERAPEUTICS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 24. GLOBAL VETERINARY THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 25. GLOBAL VETERINARY THERAPEUTICS MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
List of Tables
TABLE 1. GLOBAL VETERINARY THERAPEUTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL VETERINARY THERAPEUTICS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 3. GLOBAL VETERINARY THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 4. GLOBAL BIOLOGICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 5. GLOBAL BIOLOGICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 6. GLOBAL BIOLOGICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 7. GLOBAL CELL THERAPIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 8. GLOBAL CELL THERAPIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 9. GLOBAL CELL THERAPIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 10. GLOBAL MONOCLONAL ANTIBODIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 11. GLOBAL MONOCLONAL ANTIBODIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 12. GLOBAL MONOCLONAL ANTIBODIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 13. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 14. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 15. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 16. GLOBAL FEED ADDITIVES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 17. GLOBAL FEED ADDITIVES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 18. GLOBAL FEED ADDITIVES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 19. GLOBAL ENZYMES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 20. GLOBAL ENZYMES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 21. GLOBAL ENZYMES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 22. GLOBAL PREBIOTICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 23. GLOBAL PREBIOTICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 24. GLOBAL PREBIOTICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 25. GLOBAL PROBIOTICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 26. GLOBAL PROBIOTICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 27. GLOBAL PROBIOTICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 28. GLOBAL PARASITICIDES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 29. GLOBAL PARASITICIDES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 30. GLOBAL PARASITICIDES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 31. GLOBAL ECTOPARASITICIDES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 32. GLOBAL ECTOPARASITICIDES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 33. GLOBAL ECTOPARASITICIDES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 34. GLOBAL ENDECTOCIDES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 35. GLOBAL ENDECTOCIDES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 36. GLOBAL ENDECTOCIDES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 37. GLOBAL PHARMACEUTICALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 38. GLOBAL PHARMACEUTICALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 39. GLOBAL PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 40. GLOBAL ANTI-INFLAMMATORIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 41. GLOBAL ANTI-INFLAMMATORIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 42. GLOBAL ANTI-INFLAMMATORIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 43. GLOBAL ANTIBIOTICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 44. GLOBAL ANTIBIOTICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 45. GLOBAL ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 46. GLOBAL HORMONES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 47. GLOBAL HORMONES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 48. GLOBAL HORMONES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 49. GLOBAL VACCINES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 50. GLOBAL VACCINES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 51. GLOBAL VACCINES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 52. GLOBAL INACTIVATED MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 53. GLOBAL INACTIVATED MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 54. GLOBAL INACTIVATED MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 55. GLOBAL LIVE ATTENUATED MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 56. GLOBAL LIVE ATTENUATED MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 57. GLOBAL LIVE ATTENUATED MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 58. GLOBAL RECOMBINANT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 59. GLOBAL RECOMBINANT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 60. GLOBAL RECOMBINANT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 61. GLOBAL VETERINARY THERAPEUTICS MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 62. GLOBAL AQUACULTURE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 63. GLOBAL AQUACULTURE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 64. GLOBAL AQUACULTURE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 65. GLOBAL CRUSTACEANS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 66. GLOBAL CRUSTACEANS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 67. GLOBAL CRUSTACEANS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 68. GLOBAL FRESHWATER FISH MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 69. GLOBAL FRESHWATER FISH MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 70. GLOBAL FRESHWATER FISH MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 71. GLOBAL MARINE FISH MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 72. GLOBAL MARINE FISH MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 73. GLOBAL MARINE FISH MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 74. GLOBAL COMPANION ANIMALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 75. GLOBAL COMPANION ANIMALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 76. GLOBAL COMPANION ANIMALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 77. GLOBAL AVIAN MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 78. GLOBAL AVIAN MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 79. GLOBAL AVIAN MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 80. GLOBAL CANINE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 81. GLOBAL CANINE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 82. GLOBAL CANINE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 83. GLOBAL FELINE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 84. GLOBAL FELINE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 85. GLOBAL FELINE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 86. GLOBAL RODENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 87. GLOBAL RODENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 88. GLOBAL RODENTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 89. GLOBAL EQUINE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 90. GLOBAL EQUINE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 91. GLOBAL EQUINE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 92. GLOBAL PERFORMANCE HORSES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 93. GLOBAL PERFORMANCE HORSES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 94. GLOBAL PERFORMANCE HORSES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 95. GLOBAL RACING HORSES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 96. GLOBAL RACING HORSES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 97. GLOBAL RACING HORSES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 98. GLOBAL RECREATIONAL HORSES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 99. GLOBAL RECREATIONAL HORSES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 100. GLOBAL RECREATIONAL HORSES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 101. GLOBAL LIVESTOCK MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 102. GLOBAL LIVESTOCK MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 103. GLOBAL LIVESTOCK MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 104. GLOBAL CATTLE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 105. GLOBAL CATTLE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 106. GLOBAL CATTLE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 107. GLOBAL POULTRY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 108. GLOBAL POULTRY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 109. GLOBAL POULTRY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 110. GLOBAL SHEEP & GOATS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 111. GLOBAL SHEEP & GOATS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 112. GLOBAL SHEEP & GOATS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 113. GLOBAL SWINE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 114. GLOBAL SWINE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 115. GLOBAL SWINE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 116. GLOBAL VETERINARY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 117. GLOBAL INHALATION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 118. GLOBAL INHALATION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 119. GLOBAL INHALATION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 120. GLOBAL ORAL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 121. GLOBAL ORAL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 122. GLOBAL ORAL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 123. GLOBAL PARENTERAL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 124. GLOBAL PARENTERAL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 125. GLOBAL PARENTERAL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 126. GLOBAL INTRADERMAL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 127. GLOBAL INTRADERMAL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 128. GLOBAL INTRADERMAL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 129. GLOBAL INTRAMUSCULAR MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 130. GLOBAL INTRAMUSCULAR MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 131. GLOBAL INTRAMUSCULAR MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 132. GLOBAL INTRAVENOUS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 133. GLOBAL INTRAVENOUS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 134. GLOBAL INTRAVENOUS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 135. GLOBAL SUBCUTANEOUS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 136. GLOBAL SUBCUTANEOUS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 137. GLOBAL SUBCUTANEOUS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 138. GLOBAL TOPICAL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 139. GLOBAL TOPICAL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 140. GLOBAL TOPICAL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 141. GLOBAL VETERINARY THERAPEUTICS MARKET SIZE, BY DISEASE TYPE, 2017-2032 (USD MILLION)
TABLE 142. GLOBAL BEHAVIORAL DISORDERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 143. GLOBAL BEHAVIORAL DISORDERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 144. GLOBAL BEHAVIORAL DISORDERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 145. GLOBAL INFECTIOUS DISEASES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 146. GLOBAL INFECTIOUS DISEASES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 147. GLOBAL INFECTIOUS DISEASES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 148. GLOBAL METABOLIC DISORDERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 149. GLOBAL METABOLIC DISORDERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 150. GLOBAL METABOLIC DISORDERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 151. GLOBAL MUSCULOSKELETAL DISORDERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 152. GLOBAL MUSCULOSKELETAL DISORDERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 153. GLOBAL MUSCULOSKELETAL DISORDERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 154. GLOBAL PARASITIC DISEASES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 155. GLOBAL PARASITIC DISEASES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 156. GLOBAL PARASITIC DISEASES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 157. GLOBAL REPRODUCTIVE DISORDERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 158. GLOBAL REPRODUCTIVE DISORDERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 159. GLOBAL REPRODUCTIVE DISORDERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 160. GLOBAL VETERINARY THERAPEUTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 161. GLOBAL AMBULATORY SERVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 162. GLOBAL AMBULATORY SERVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 163. GLOBAL AMBULATORY SERVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 164. GLOBAL ONLINE CHANNELS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 165. GLOBAL ONLINE CHANNELS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 166. GLOBAL ONLINE CHANNELS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 167. GLOBAL RETAIL PHARMACIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 168. GLOBAL RETAIL PHARMACIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 169. GLOBAL RETAIL PHARMACIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 170. GLOBAL VETERINARY HOSPITALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 171. GLOBAL VETERINARY HOSPITALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 172. GLOBAL VETERINARY HOSPITALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 173. GLOBAL VETERINARY THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 174. GLOBAL DIRECT SALES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 175. GLOBAL DIRECT SALES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 176. GLOBAL DIRECT SALES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 177. GLOBAL E-COMMERCE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 178. GLOBAL E-COMMERCE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 179. GLOBAL E-COMMERCE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 180. GLOBAL HOSPITAL PHARMACIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 181. GLOBAL HOSPITAL PHARMACIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 182. GLOBAL HOSPITAL PHARMACIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 183. GLOBAL RETAIL PHARMACIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 184. GLOBAL RETAIL PHARMACIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 185. GLOBAL RETAIL PHARMACIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 186. GLOBAL VETERINARY THERAPEUTICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 187. ASIA-PACIFIC VETERINARY THERAPEUTICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 188. ASIA-PACIFIC VETERINARY THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 189. ASIA-PACIFIC VETERINARY THERAPEUTICS MARKET SIZE, BY BIOLOGICS, 2017-2032 (USD MILLION)
TABLE 190. ASIA-PACIFIC VETERINARY THERAPEUTICS MARKET SIZE, BY FEED ADDITIVES, 2017-2032 (USD MILLION)
TABLE 191. ASIA-PACIFIC VETERINARY THERAPEUTICS MARKET SIZE, BY PARASITICIDES, 2017-2032 (USD MILLION)
TABLE 192. ASIA-PACIFIC VETERINARY THERAPEUTICS MARKET SIZE, BY PHARMACEUTICALS, 2017-2032 (USD MILLION)
TABLE 193. ASIA-PACIFIC VETERINARY THERAPEUTICS MARKET SIZE, BY VACCINES, 2017-2032 (USD MILLION)
TABLE 194. ASIA-PACIFIC VETERINARY THERAPEUTICS MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 195. ASIA-PACIFIC VETERINARY THERAPEUTICS MARKET SIZE, BY AQUACULTURE, 2017-2032 (USD MILLION)
TABLE 196. ASIA-PACIFIC VETERINARY THERAPEUTICS MARKET SIZE, BY COMPANION ANIMALS, 2017-2032 (USD MILLION)
TABLE 197. ASIA-PACIFIC VETERINARY THERAPEUTICS MARKET SIZE, BY EQUINE, 2017-2032 (USD MILLION)
TABLE 198. ASIA-PACIFIC VETERINARY THERAPEUTICS MARKET SIZE, BY LIVESTOCK, 2017-2032 (USD MILLION)
TABLE 199. ASIA-PACIFIC VETERINARY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 200. ASIA-PACIFIC VETERINARY THERAPEUTICS MARKET SIZE, BY PARENTERAL, 2017-2032 (USD MILLION)
TABLE 201. ASIA-PACIFIC VETERINARY THERAPEUTICS MARKET SIZE, BY DISEASE TYPE, 2017-2032 (USD MILLION)
TABLE 202. ASIA-PACIFIC VETERINARY THERAPEUTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 203. ASIA-PACIFIC VETERINARY THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 204. NORTH AMERICA VETERINARY THERAPEUTICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 205. NORTH AMERICA VETERINARY THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 206. NORTH AMERICA VETERINARY THERAPEUTICS MARKET SIZE, BY BIOLOGICS, 2017-2032 (USD MILLION)
TABLE 207. NORTH AMERICA VETERINARY THERAPEUTICS MARKET SIZE, BY FEED ADDITIVES, 2017-2032 (USD MILLION)
TABLE 208. NORTH AMERICA VETERINARY THERAPEUTICS MARKET SIZE, BY PARASITICIDES, 2017-2032 (USD MILLION)
TABLE 209. NORTH AMERICA VETERINARY THERAPEUTICS MARKET SIZE, BY PHARMACEUTICALS, 2017-2032 (USD MILLION)
TABLE 210. NORTH AMERICA VETERINARY THERAPEUTICS MARKET SIZE, BY VACCINES, 2017-2032 (USD MILLION)
TABLE 211. NORTH AMERICA VETERINARY THERAPEUTICS MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 212. NORTH AMERICA VETERINARY THERAPEUTICS MARKET SIZE, BY AQUACULTURE, 2017-2032 (USD MILLION)
TABLE 213. NORTH AMERICA VETERINARY THERAPEUTICS MARKET SIZE, BY COMPANION ANIMALS, 2017-2032 (USD MILLION)
TABLE 214. NORTH AMERICA VETERINARY THERAPEUTICS MARKET SIZE, BY EQUINE, 2017-2032 (USD MILLION)
TABLE 215. NORTH AMERICA VETERINARY THERAPEUTICS MARKET SIZE, BY LIVESTOCK, 2017-2032 (USD MILLION)
TABLE 216. NORTH AMERICA VETERINARY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 217. NORTH AMERICA VETERINARY THERAPEUTICS MARKET SIZE, BY PARENTERAL, 2017-2032 (USD MILLION)
TABLE 218. NORTH AMERICA VETERINARY THERAPEUTICS MARKET SIZE, BY DISEASE TYPE, 2017-2032 (USD MILLION)
TABLE 219. NORTH AMERICA VETERINARY THERAPEUTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 220. NORTH AMERICA VETERINARY THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 221. LATIN AMERICA VETERINARY THERAPEUTICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 222. LATIN AMERICA VETERINARY THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 223. LATIN AMERICA VETERINARY THERAPEUTICS MARKET SIZE, BY BIOLOGICS, 2017-2032 (USD MILLION)
TABLE 224. LATIN AMERICA VETERINARY THERAPEUTICS MARKET SIZE, BY FEED ADDITIVES, 2017-2032 (USD MILLION)
TABLE 225. LATIN AMERICA VETERINARY THERAPEUTICS MARKET SIZE, BY PARASITICIDES, 2017-2032 (USD MILLION)
TABLE 226. LATIN AMERICA VETERINARY THERAPEUTICS MARKET SIZE, BY PHARMACEUTICALS, 2017-2032 (USD MILLION)
TABLE 227. LATIN AMERICA VETERINARY THERAPEUTICS MARKET SIZE, BY VACCINES, 2017-2032 (USD MILLION)
TABLE 228. LATIN AMERICA VETERINARY THERAPEUTICS MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 229. LATIN AMERICA VETERINARY THERAPEUTICS MARKET SIZE, BY AQUACULTURE, 2017-2032 (USD MILLION)
TABLE 230. LATIN AMERICA VETERINARY THERAPEUTICS MARKET SIZE, BY COMPANION ANIMALS, 2017-2032 (USD MILLION)
TABLE 231. LATIN AMERICA VETERINARY THERAPEUTICS MARKET SIZE, BY EQUINE, 2017-2032 (USD MILLION)
TABLE 232. LATIN AMERICA VETERINARY THERAPEUTICS MARKET SIZE, BY LIVESTOCK, 2017-2032 (USD MILLION)
TABLE 233. LATIN AMERICA VETERINARY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 234. LATIN AMERICA VETERINARY THERAPEUTICS MARKET SIZE, BY PARENTERAL, 2017-2032 (USD MILLION)
TABLE 235. LATIN AMERICA VETERINARY THERAPEUTICS MARKET SIZE, BY DISEASE TYPE, 2017-2032 (USD MILLION)
TABLE 236. LATIN AMERICA VETERINARY THERAPEUTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 237. LATIN AMERICA VETERINARY THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 238. EUROPE VETERINARY THERAPEUTICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 239. EUROPE VETERINARY THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 240. EUROPE VETERINARY THERAPEUTICS MARKET SIZE, BY BIOLOGICS, 2017-2032 (USD MILLION)
TABLE 241. EUROPE VETERINARY THERAPEUTICS MARKET SIZE, BY FEED ADDITIVES, 2017-2032 (USD MILLION)
TABLE 242. EUROPE VETERINARY THERAPEUTICS MARKET SIZE, BY PARASITICIDES, 2017-2032 (USD MILLION)
TABLE 243. EUROPE VETERINARY THERAPEUTICS MARKET SIZE, BY PHARMACEUTICALS, 2017-2032 (USD MILLION)
TABLE 244. EUROPE VETERINARY THERAPEUTICS MARKET SIZE, BY VACCINES, 2017-2032 (USD MILLION)
TABLE 245. EUROPE VETERINARY THERAPEUTICS MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 246. EUROPE VETERINARY THERAPEUTICS MARKET SIZE, BY AQUACULTURE, 2017-2032 (USD MILLION)
TABLE 247. EUROPE VETERINARY THERAPEUTICS MARKET SIZE, BY COMPANION ANIMALS, 2017-2032 (USD MILLION)
TABLE 248. EUROPE VETERINARY THERAPEUTICS MARKET SIZE, BY EQUINE, 2017-2032 (USD MILLION)
TABLE 249. EUROPE VETERINARY THERAPEUTICS MARKET SIZE, BY LIVESTOCK, 2017-2032 (USD MILLION)
TABLE 250. EUROPE VETERINARY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 251. EUROPE VETERINARY THERAPEUTICS MARKET SIZE, BY PARENTERAL, 2017-2032 (USD MILLION)
TABLE 252. EUROPE VETERINARY THERAPEUTICS MARKET SIZE, BY DISEASE TYPE, 2017-2032 (USD MILLION)
TABLE 253. EUROPE VETERINARY THERAPEUTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 254. EUROPE VETERINARY THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 255. MIDDLE EAST VETERINARY THERAPEUTICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 256. MIDDLE EAST VETERINARY THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 257. MIDDLE EAST VETERINARY THERAPEUTICS MARKET SIZE, BY BIOLOGICS, 2017-2032 (USD MILLION)
TABLE 258. MIDDLE EAST VETERINARY THERAPEUTICS MARKET SIZE, BY FEED ADDITIVES, 2017-2032 (USD MILLION)
TABLE 259. MIDDLE EAST VETERINARY THERAPEUTICS MARKET SIZE, BY PARASITICIDES, 2017-2032 (USD MILLION)
TABLE 260. MIDDLE EAST VETERINARY THERAPEUTICS MARKET SIZE, BY PHARMACEUTICALS, 2017-2032 (USD MILLION)
TABLE 261. MIDDLE EAST VETERINARY THERAPEUTICS MARKET SIZE, BY VACCINES, 2017-2032 (USD MILLION)
TABLE 262. MIDDLE EAST VETERINARY THERAPEUTICS MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 263. MIDDLE EAST VETERINARY THERAPEUTICS MARKET SIZE, BY AQUACULTURE, 2017-2032 (USD MILLION)
TABLE 264. MIDDLE EAST VETERINARY THERAPEUTICS MARKET SIZE, BY COMPANION ANIMALS, 2017-2032 (USD MILLION)
TABLE 265. MIDDLE EAST VETERINARY THERAPEUTICS MARKET SIZE, BY EQUINE, 2017-2032 (USD MILLION)
TABLE 266. MIDDLE EAST VETERINARY THERAPEUTICS MARKET SIZE, BY LIVESTOCK, 2017-2032 (USD MILLION)
TABLE 267. MIDDLE EAST VETERINARY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 268. MIDDLE EAST VETERINARY THERAPEUTICS MARKET SIZE, BY PARENTERAL, 2017-2032 (USD MILLION)
TABLE 269. MIDDLE EAST VETERINARY THERAPEUTICS MARKET SIZE, BY DISEASE TYPE, 2017-2032 (USD MILLION)
TABLE 270. MIDDLE EAST VETERINARY THERAPEUTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 271. MIDDLE EAST VETERINARY THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 272. AFRICA VETERINARY THERAPEUTICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 273. AFRICA VETERINARY THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 274. AFRICA VETERINARY THERAPEUTICS MARKET SIZE, BY BIOLOGICS, 2017-2032 (USD MILLION)
TABLE 275. AFRICA VETERINARY THERAPEUTICS MARKET SIZE, BY FEED ADDITIVES, 2017-2032 (USD MILLION)
TABLE 276. AFRICA VETERINARY THERAPEUTICS MARKET SIZE, BY PARASITICIDES, 2017-2032 (USD MILLION)
TABLE 277. AFRICA VETERINARY THERAPEUTICS MARKET SIZE, BY PHARMACEUTICALS, 2017-2032 (USD MILLION)
TABLE 278. AFRICA VETERINARY THERAPEUTICS MARKET SIZE, BY VACCINES, 2017-2032 (USD MILLION)
TABLE 279. AFRICA VETERINARY THERAPEUTICS MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 280. AFRICA VETERINARY THERAPEUTICS MARKET SIZE, BY AQUACULTURE, 2017-2032 (USD MILLION)
TABLE 281. AFRICA VETERINARY THERAPEUTICS MARKET SIZE, BY COMPANION ANIMALS, 2017-2032 (USD MILLION)
TABLE 282. AFRICA VETERINARY THERAPEUTICS MARKET SIZE, BY EQUINE, 2017-2032 (USD MILLION)
TABLE 283. AFRICA VETERINARY THERAPEUTICS MARKET SIZE, BY LIVESTOCK, 2017-2032 (USD MILLION)
TABLE 284. AFRICA VETERINARY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 285. AFRICA VETERINARY THERAPEUTICS MARKET SIZE, BY PARENTERAL, 2017-2032 (USD MILLION)
TABLE 286. AFRICA VETERINARY THERAPEUTICS MARKET SIZE, BY DISEASE TYPE, 2017-2032 (USD MILLION)
TABLE 287. AFRICA VETERINARY THERAPEUTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 288. AFRICA VETERINARY THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 289. GLOBAL VETERINARY THERAPEUTICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 290. ASEAN VETERINARY THERAPEUTICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 291. ASEAN VETERINARY THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 292. ASEAN VETERINARY THERAPEUTICS MARKET SIZE, BY BIOLOGICS, 2017-2032 (USD MILLION)
TABLE 293. ASEAN VETERINARY THERAPEUTICS MARKET SIZE, BY FEED ADDITIVES, 2017-2032 (USD MILLION)
TABLE 294. ASEAN VETERINARY THERAPEUTICS MARKET SIZE, BY PARASITICIDES, 2017-2032 (USD MILLION)
TABLE 295. ASEAN VETERINARY THERAPEUTICS MARKET SIZE, BY PHARMACEUTICALS, 2017-2032 (USD MILLION)
TABLE 296. ASEAN VETERINARY THERAPEUTICS MARKET SIZE, BY VACCINES, 2017-2032 (USD MILLION)
TABLE 297. ASEAN VETERINARY THERAPEUTICS MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 298. ASEAN VETERINARY THERAPEUTICS MARKET SIZE, BY AQUACULTURE, 2017-2032 (USD MILLION)
TABLE 299. ASEAN VETERINARY THERAPEUTICS MARKET SIZE, BY COMPANION ANIMALS, 2017-2032 (USD MILLION)
TABLE 300. ASEAN VETERINARY THERAPEUTICS MARKET SIZE, BY EQUINE, 2017-2032 (USD MILLION)
TABLE 301. ASEAN VETERINARY THERAPEUTICS MARKET SIZE, BY LIVESTOCK, 2017-2032 (USD MILLION)
TABLE 302. ASEAN VETERINARY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 303. ASEAN VETERINARY THERAPEUTICS MARKET SIZE, BY PARENTERAL, 2017-2032 (USD MILLION)
TABLE 304. ASEAN VETERINARY THERAPEUTICS MARKET SIZE, BY DISEASE TYPE, 2017-2032 (USD MILLION)
TABLE 305. ASEAN VETERINARY THERAPEUTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 306. ASEAN VETERINARY THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 307. GCC VETERINARY THERAPEUTICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 308. GCC VETERINARY THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 309. GCC VETERINARY THERAPEUTICS MARKET SIZE, BY BIOLOGICS, 2017-2032 (USD MILLION)
TABLE 310. GCC VETERINARY THERAPEUTICS MARKET SIZE, BY FEED ADDITIVES, 2017-2032 (USD MILLION)
TABLE 311. GCC VETERINARY THERAPEUTICS MARKET SIZE, BY PARASITICIDES, 2017-2032 (USD MILLION)
TABLE 312. GCC VETERINARY THERAPEUTICS MARKET SIZE, BY PHARMACEUTICALS, 2017-2032 (USD MILLION)
TABLE 313. GCC VETERINARY THERAPEUTICS MARKET SIZE, BY VACCINES, 2017-2032 (USD MILLION)
TABLE 314. GCC VETERINARY THERAPEUTICS MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 315. GCC VETERINARY THERAPEUTICS MARKET SIZE, BY AQUACULTURE, 2017-2032 (USD MILLION)
TABLE 316. GCC VETERINARY THERAPEUTICS MARKET SIZE, BY COMPANION ANIMALS, 2017-2032 (USD MILLION)
TABLE 317. GCC VETERINARY THERAPEUTICS MARKET SIZE, BY EQUINE, 2017-2032 (USD MILLION)
TABLE 318. GCC VETERINARY THERAPEUTICS MARKET SIZE, BY LIVESTOCK, 2017-2032 (USD MILLION)
TABLE 319. GCC VETERINARY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 320. GCC VETERINARY THERAPEUTICS MARKET SIZE, BY PARENTERAL, 2017-2032 (USD MILLION)
TABLE 321. GCC VETERINARY THERAPEUTICS MARKET SIZE, BY DISEASE TYPE, 2017-2032 (USD MILLION)
TABLE 322. GCC VETERINARY THERAPEUTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 323. GCC VETERINARY THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 324. EUROPEAN UNION VETERINARY THERAPEUTICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 325. EUROPEAN UNION VETERINARY THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 326. EUROPEAN UNION VETERINARY THERAPEUTICS MARKET SIZE, BY BIOLOGICS, 2017-2032 (USD MILLION)
TABLE 327. EUROPEAN UNION VETERINARY THERAPEUTICS MARKET SIZE, BY FEED ADDITIVES, 2017-2032 (USD MILLION)
TABLE 328. EUROPEAN UNION VETERINARY THERAPEUTICS MARKET SIZE, BY PARASITICIDES, 2017-2032 (USD MILLION)
TABLE 329. EUROPEAN UNION VETERINARY THERAPEUTICS MARKET SIZE, BY PHARMACEUTICALS, 2017-2032 (USD MILLION)
TABLE 330. EUROPEAN UNION VETERINARY THERAPEUTICS MARKET SIZE, BY VACCINES, 2017-2032 (USD MILLION)
TABLE 331. EUROPEAN UNION VETERINARY THERAPEUTICS MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 332. EUROPEAN UNION VETERINARY THERAPEUTICS MARKET SIZE, BY AQUACULTURE, 2017-2032 (USD MILLION)
TABLE 333. EUROPEAN UNION VETERINARY THERAPEUTICS MARKET SIZE, BY COMPANION ANIMALS, 2017-2032 (USD MILLION)
TABLE 334. EUROPEAN UNION VETERINARY THERAPEUTICS MARKET SIZE, BY EQUINE, 2017-2032 (USD MILLION)
TABLE 335. EUROPEAN UNION VETERINARY THERAPEUTICS MARKET SIZE, BY LIVESTOCK, 2017-2032 (USD MILLION)
TABLE 336. EUROPEAN UNION VETERINARY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 337. EUROPEAN UNION VETERINARY THERAPEUTICS MARKET SIZE, BY PARENTERAL, 2017-2032 (USD MILLION)
TABLE 338. EUROPEAN UNION VETERINARY THERAPEUTICS MARKET SIZE, BY DISEASE TYPE, 2017-2032 (USD MILLION)
TABLE 339. EUROPEAN UNION VETERINARY THERAPEUTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 340. EUROPEAN UNION VETERINARY THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 341. BRICS VETERINARY THERAPEUTICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 342. BRICS VETERINARY THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 343. BRICS VETERINARY THERAPEUTICS MARKET SIZE, BY BIOLOGICS, 2017-2032 (USD MILLION)
TABLE 344. BRICS VETERINARY THERAPEUTICS MARKET SIZE, BY FEED ADDITIVES, 2017-2032 (USD MILLION)
TABLE 345. BRICS VETERINARY THERAPEUTICS MARKET SIZE, BY PARASITICIDES, 2017-2032 (USD MILLION)
TABLE 346. BRICS VETERINARY THERAPEUTICS MARKET SIZE, BY PHARMACEUTICALS, 2017-2032 (USD MILLION)
TABLE 347. BRICS VETERINARY THERAPEUTICS MARKET SIZE, BY VACCINES, 2017-2032 (USD MILLION)
TABLE 348. BRICS VETERINARY THERAPEUTICS MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 349. BRICS VETERINARY THERAPEUTICS MARKET SIZE, BY AQUACULTURE, 2017-2032 (USD MILLION)
TABLE 350. BRICS VETERINARY THERAPEUTICS MARKET SIZE, BY COMPANION ANIMALS, 2017-2032 (USD MILLION)
TABLE 351. BRICS VETERINARY THERAPEUTICS MARKET SIZE, BY EQUINE, 2017-2032 (USD MILLION)
TABLE 352. BRICS VETERINARY THERAPEUTICS MARKET SIZE, BY LIVESTOCK, 2017-2032 (USD MILLION)
TABLE 353. BRICS VETERINARY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 354. BRICS VETERINARY THERAPEUTICS MARKET SIZE, BY PARENTERAL, 2017-2032 (USD MILLION)
TABLE 355. BRICS VETERINARY THERAPEUTICS MARKET SIZE, BY DISEASE TYPE, 2017-2032 (USD MILLION)
TABLE 356. BRICS VETERINARY THERAPEUTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 357. BRICS VETERINARY THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 358. G7 VETERINARY THERAPEUTICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 359. G7 VETERINARY THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 360. G7 VETERINARY THERAPEUTICS MARKET SIZE, BY BIOLOGICS, 2017-2032 (USD MILLION)
TABLE 361. G7 VETERINARY THERAPEUTICS MARKET SIZE, BY FEED ADDITIVES, 2017-2032 (USD MILLION)
TABLE 362. G7 VETERINARY THERAPEUTICS MARKET SIZE, BY PARASITICIDES, 2017-2032 (USD MILLION)
TABLE 363. G7 VETERINARY THERAPEUTICS MARKET SIZE, BY PHARMACEUTICALS, 2017-2032 (USD MILLION)
TABLE 364. G7 VETERINARY THERAPEUTICS MARKET SIZE, BY VACCINES, 2017-2032 (USD MILLION)
TABLE 365. G7 VETERINARY THERAPEUTICS MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 366. G7 VETERINARY THERAPEUTICS MARKET SIZE, BY AQUACULTURE, 2017-2032 (USD MILLION)
TABLE 367. G7 VETERINARY THERAPEUTICS MARKET SIZE, BY COMPANION ANIMALS, 2017-2032 (USD MILLION)
TABLE 368. G7 VETERINARY THERAPEUTICS MARKET SIZE, BY EQUINE, 2017-2032 (USD MILLION)
TABLE 369. G7 VETERI

Companies Mentioned

  • Ashish Life Science Private Limited
  • Biogenesis Bago S.A.
  • Boehringer Ingelheim International GmbH
  • Ceva Santé Animale
  • Dechra Pharmaceuticals PLC
  • Elanco Animal Health Incorporated
  • Hester Biosciences Limited
  • HIPRA, S.A.
  • Huvepharma EOOD
  • Indian Immunologicals Limited
  • Inovet Group
  • Intas Pharmaceuticals Limited
  • Kyoritsu Seiyaku Corporation
  • Merck & Co., Inc.
  • Neogen Corporation
  • Norbrook Laboratories Limited
  • Novartis AG
  • Ourofino Saúde Animal Participações S.A.
  • Phibro Animal Health Corporation
  • Sanofi S.A.
  • SeQuent Scientific Limited
  • Venkys (India) Limited
  • Vetoquinol S.A.
  • Virbac S.A.
  • Zoetis Inc.
  • Zydus Lifesciences Limited

Table Information

Report AttributeDetails
No. of Pages194
PublishedAugust 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 55.36 Billion
Forecasted Market Value ( USD ) by 2032 $ 78.29 Billion
Compound Annual Growth Rate5.7%
Regions CoveredGlobal
No. of Companies Mentioned26

Related Topics

Related Reports

Europe Veterinary Pharmaceuticals Market, Competition, Forecast and Opportunities, 2018-2028 - Product Image

Europe Veterinary Pharmaceuticals Market, Competition, Forecast and Opportunities, 2018-2028

  • Report
  • 132 Pages
  • Europe
From
MEA Veterinary Pharmaceutical Market Forecasts from 2023 to 2028 - Product Image

MEA Veterinary Pharmaceutical Market Forecasts from 2023 to 2028

  • Report
  • 98 Pages
  • Africa, Middle East
From
A Practical Approach to Developing the CMC Package for Veterinary Pharmaceutical Products (November 2, 2027) - Product Image

A Practical Approach to Developing the CMC Package for Veterinary Pharmaceutical Products (November 2, 2027)

  • Training
  • 1 Day
  • Global
Veterinary Drug Market - Global Forecast 2026-2032 - Product Image

Veterinary Drug Market - Global Forecast 2026-2032

  • Report
  • 180 Pages
  • Global
From
Animal Health Market - Global Forecast 2026-2032 - Product Image

Animal Health Market - Global Forecast 2026-2032

  • Report
  • 197 Pages
  • Global
From

About the Animal Pharmaceuticals Market

The Animal Pharmaceuticals market is a sector of the pharmaceutical industry that focuses on the development and production of drugs and other medical products for animals. These products are used to treat, prevent, and diagnose diseases in animals, as well as to improve their health and well-being. Animal pharmaceuticals are used in a variety of species, including companion animals, livestock, and wildlife. Animal pharmaceuticals are regulated by the Food and Drug Administration (FDA) and the Veterinary Medicine Advisory Committee (VMAC). The FDA is responsible for ensuring the safety and efficacy of animal drugs, while the VMAC provides advice and guidance on the development and approval of animal drugs. Some of the major companies in the Animal Pharmaceuticals market include Zoetis, Merck Animal Health, Elanco Animal Health, Bayer Animal Health, and Boehringer Ingelheim Animal Health. These companies are involved in the development, production, and marketing of animal pharmaceuticals. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.